Last updated: 07/23/2024 12:40:25
APPaRENT 3 (Asthma Patients’ and Physicians’ peRspectives on the burden and managemENT of asthma studies) in Thailand, Malaysia, Indonesia, Philippines, Saudi Arabia and UAE
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: APPaRENT 3 (Asthma Patients’ and Physicians’ peRspectives on the burden and managemENT of asthma studies) in Thailand, Malaysia, Indonesia, Philippines, Saudi Arabia and UAE
Trial description: This is an observational study utilising online survey of asthma participants and physicians. The study aims to address the attitudes, beliefs and treatment practices about asthma and its management among participants and physicians.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Percentage of participant and physician perspectives on attitudes, beliefs, and treatment practices about asthma and asthma management in regular dosing versus flexible dosing
Timeframe: Survey duration is 3 months
Percentage of participant and physician perspectives regarding asthma management and treatment practices
Timeframe: Survey duration is 3 months
Percentage of participant and physician perspectives regarding facilitators and barriers to participant asthma management and adherence to prescribed management and treatment
Timeframe: Survey duration is 3 months
Percentage of participant and physician perspectives regarding physician treatment approaches and adherence to Global Initiative for Asthma (GINA) guidelines
Timeframe: Survey duration is 3 months
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
2023-30-11
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Not applicable
Medical condition
Asthma
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
October 2023 to November 2023
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
18+ years
Accepts healthy volunteers
No
- Asthma Participants and Caregivers:
- Male and female participants aged 18 years or older.
- Physicians: Having responsibility for drug formulary decisions or currently work for a pharmaceutical company.
Inclusion and exclusion criteria
Inclusion criteria:
- Male and female participants aged 18 years or older.
- Participants with history of current or past diagnosis of asthma by a physician.
- Having access to internet. Physicians:
- Physician group consists of primary care physicians including general practitioners, family medicine, and/or internal medicine physicians. Physician group will also include pulmonologists.
- Personally responsible for the treatment and management of participants with asthma.
- At least three years in clinical practice.
- Treats at least four asthma participants per month on average.
- Having access to internet.
Asthma Participants and Caregivers:
Exclusion criteria:
- Physicians: Having responsibility for drug formulary decisions or currently work for a pharmaceutical company.
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Protocol
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
2023-30-11
Actual study completion date
2023-30-11
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website